Clinical Trials Browser

Phase NA × Gastrointestinal Neoplasms × Aprepitant × Clear all

NCT01504711 2021-04-08

Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy

Phase NA Completed

30 enrolled 12 charts

Gastrointestinal

Gastrointestinal Neoplasms

NCT02550119 2017-03-28

Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy

Phase NA Terminated

Gastrointestinal

Gastrointestinal Neoplasms, Nausea, Vomiting